Log In
BCIQ
Print this Print this
 

Annamycin (L-Annamycin)

  Manage Alerts
Collapse Summary General Information
Company Moleculin Biotech Inc.
DescriptionLiposomal anthracycline analog designed to evade the P glycoprotein (Pgp; MDR1) multidrug resistance pump
Molecular Target DNA
Mechanism of ActionTopoisomerase II inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/01/2015

Undisclosed

0

0

Get a free BioCentury trial today